SELF-TEST FOR GLUCOSE - ANVISA Registration 81414021696

Access comprehensive regulatory information for SELF-TEST FOR GLUCOSE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81414021696 and manufactured by ROCHE DIABETES CARE GMBH. The registration is held by ROCHE DIABETES CARE BRASIL LTDA with validity until Jun 11, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including OK BIOTECH CO., LTD., ROCHE DIABETES CARE GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.